---
title: "Nemaura Medical reveals details of upcoming European launch and recent patient feedback"
image: "https:\/\/i.ytimg.com\/vi\/PizsAFNdUfQ\/hqdefault.jpg"
vid_id: "PizsAFNdUfQ"
categories: "News-Politics"
tags: ["Nemaura","Medical","reveals"]
date: "2021-11-14T01:55:42+03:00"
vid_date: "2019-10-08T15:52:03Z"
duration: "PT4M53S"
viewcount: "1797"
likeCount: ""
dislikeCount: ""
channel: "Proactive"
---
{% raw %}Nemaura Medical Inc (NASDAQ:NMRD) Vice President of Strategy &amp; Strategic Alliances Dr Fred Schaebsdau tells Proactive the medical technology company is targeting a commercial launch for its flagship SugarBEAT continuous glucose monitor in the UK and in Ireland in January 2020.<br /><br />Dr Schaebsdau adds that recently, the Nemaura team presented positive feedback from its first patient-user experiences at the 55th Annual Meeting of the European Association for the Study of Diabetes.{% endraw %}
